This document provides an overview of the public drug plans in each province in alphabetical order. Read more on who qualifies for the program, what the deductible, premium and co payment is, who pays for medications first and where additional information can be...
There are a number of biosimilar medications available to treat people with arthritis in Canada. A biosimilar is a biologic drug that is highly similar to a biologic drug that was already authorized for sale. Health Canada has recently updated its fact sheet on...
For Kids Living with Arthritis and Their Parents We have developed this resource to help kids with arthritis manage taking methotrexate, an important medication for people who live with different types of arthritis. This resource is based on information from a survey...
With healthcare providers, we have developed this resource for you about methotrexate. Methotrexate is an important medication in treating some forms of arthritis and we know that some people find taking methotrexate a challenge. This booklet tells you a bit more...
This resource is part of a number of projects under the theme of TEAM (Together Enhancing Arthritis Management). By the end of the session, you will: Understand the goals of treatment in inflammatory arthritis Understand the role of medications in treating...
CAPA heard about Manulife’s DrugWatch Program and wanted to fully understand it and provide you with information about it. Below is an article that we have developed on the Program and how it may affect you. We thank our colleagues at Manulife, Lisa Callagan and...
